Moleculin Biotech, Inc. - MBRX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$309K
QoQ value delta ($000)
-$96K
(-23.7%)
Implied price effect (QoQ)
+523.6%
Shares
Total shares
95,220
QoQ shares delta
-683,053
(-87.77%)
Total shares held by funds (by quarter)
Market chart (MBRX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q2 2026 data: only 18 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| CITADEL ADVISORS LLC | 109 | 33,085 | 0.0% |
| JANE STREET GROUP, LLC | 74 | 22,550 | 0.0% |
| VANGUARD GROUP INC | 51 | 15,544 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 50 | 15,138 | 0.0% |
| UBS Group AG | 19 | 5,863 | 0.0% |
| Tower Research Capital LLC (TRC) | 4 | 1,393 | 0.0% |
| BlackRock, Inc. | 1 | 495 | 0.0% |
| EFG International AG | 1 | 434 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 36 | 0.0% |
| DANSKE BANK A/S | 0 | 2 | 0.0% |
| MORGAN STANLEY | 0 | 36 | 0.0% |
| OSAIC HOLDINGS, INC. | 0 | 1 | 0.0% |
| Pinnacle Wealth Planning Services, Inc. | 0 | 281 | 0.0% |
| Rockefeller Capital Management L.P. | 0 | 218 | 0.0% |
| CVA Family Office, LLC | 0 | 1 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 29 | 0.0% |
| Newbridge Financial Services Group, Inc. | 0 | 114 | 0.0% |